Niro Ramachandran - Nov 19, 2021 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role: Chief Business Officer
Signature: /s/ Niro Ramachandran, Ph.D., by Brian McKelligon, as Attorney-in-Fact
Stock symbol: AKYA
Transactions as of: Nov 19, 2021
Transactions value $: $329,231
Form type: 4
Date filed: 11/22/2021, 07:27 PM
Next filing: Mar 25, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AKYA	Common Stock	Purchase	$938	+73		$12.85	73	Nov 19, 2021	Direct
transaction	AKYA	Common Stock	Purchase	$328K	+25K	+34246.58%	$13.13	25.1K	Nov 22, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Column 4 reflects a weighted average price. Shares were sold in multiple transactions at prices ranging from $12.94-$13.1699. Reporting person undertakes to provide issuer, securityholder of issuer or SEC staff, upon request, information regarding number of shares sold at each separate price within ranges set forth herein.